Drug Information

Drug General Information
Drug ID
D07OAD
Former ID
DNCL002383
Drug Name
GO-203-2c
Indication Late-stage solid tumors [ICD9: 140-199, 210-229; ICD10:C00-C75, C7A, C7B, D10-D36, D3A] Phase 1/2 [524854]
Company
Genus Oncology
Target and Pathway
Target(s) Mucin 1 Target Info Inhibitor [550809]
WikiPathways Hematopoietic Stem Cell Differentiation
References
Ref 524854ClinicalTrials.gov (NCT02204085) A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia. U.S. National Institutes of Health.
Ref 550809Clinical pipeline report, company report or official report of Genus Oncology.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.